Research at PCOM
Expanding use of medicinal cannabis
The rapid expansion of cannabis use for serious medical conditions across 33 states,
the District of Columbia, Puerto Rico, U.S. Virgin Islands and Guam reflects the mounting
recognition of the drug’s therapeutic potential for a number of disorders and diseases.
Although some of cannabis’ medicinal properties are well documented, rigorous research
is needed to identify which patients will benefit from the drug, the most effective
method of treatment, benefits versus risks and barriers to use.
Medical marijuana research in Pennsylvania
Pennsylvania is first in the nation to require that research accompany legalization
of cannabis for serious medical conditions, thereby positioning the Commonwealth as
the leader in generating new knowledge that further defines the drug’s therapeutic
Pennsylvania's authorizing legislation required that research accompany the legalization
of cannabis for medical conditions, thereby positioning the Commonwealth as the leader
in generating new knowledge regarding the therapeutic applications of cannabis.
PCOM's medicinal cannabis research programs
PCOM, in collaboration with its Clinical Registrant partner Organic Remedies, has developed a multi-study research program that will contribute data and insights
into medicinal cannabis’ use across populations, its impact on behavioral health and
quality of life, and the drug’s therapeutic potential for the treatment of chronic pain and opioid management.